[Construction of a recombinant shRNA expression vector targeting EZH2 gene and its inhibitory effect on colon...

Area of Science:

• Molecular Biology
• Cancer Research
• Gene Silencing

Background:

• Enhancer of Zeste Homolog 2 (EZH2) is a key epigenetic regulator implicated in various cancers.
• Dysregulation of EZH2 contributes to the proliferation and progression of colon adenocarcinoma.
• Targeting EZH2 offers a potential therapeutic avenue for colon cancer treatment.

Purpose of the Study:

• To construct a recombinant short hairpin RNA (shRNA) expression vector targeting the EZH2 gene.
• To evaluate the efficacy of the constructed shRNA vector in inhibiting EZH2 expression in SW480 cells.
• To determine the effect of EZH2 gene silencing on the proliferation of colon adenocarcinoma SW480 cells.

Main Methods:

• Design and cloning of an shRNA sequence targeting EZH2 cDNA into the PGFP-V-RS vector.
• Transfection of the recombinant shRNA vector into SW480 cells.
• Quantitative assessment of EZH2 mRNA and protein levels using RT-PCR and Western blot.
• Evaluation of cell viability and proliferation inhibition using MTT assays.

Main Results:

• Successful construction and identification of the recombinant shRNA expression vector targeting EZH2.
• Significant reduction in EZH2 mRNA and protein levels in SW480 cells transfected with the shRNA vector compared to controls (P < 0.01, P < 0.05).
• Demonstrated inhibition of SW480 cell growth by 30.7% at 48 hours and 25.9% at 72 hours post-transfection (P < 0.05).

Conclusions:

• A functional shRNA expression vector targeting EZH2 has been successfully constructed.
• EZH2 gene silencing via shRNA significantly inhibits the proliferation of colon adenocarcinoma SW480 cells.
• This study provides a foundation for investigating EZH2's role in tumor biology and developing targeted therapies.